```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PTEN-induced kinase 1 (PINK1) gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to exert neuroprotective effect on SN dopaminergic cells by acting as a mitochondrial Ser/Thr protein kinase.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as loss of neuroprotective effect in SN dopaminergic cells due to mutated PINK1's impaired Ser/Thr kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1 is required for maintaining mitochondrial membrane potential (ΔΨm) and mitochondrial morphology of cultured SN dopaminergic neurons and exerts its neuroprotective effect by inhibiting ROS formation.",
          "judgment": "Yes",
          "reasoning": "The assays used (mitochondrial membrane potential, morphology, and ROS formation) are directly relevant to the defined disease mechanism of mitochondrial dysfunction leading to neurodegeneration.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "PINK1-/- SN dopaminergic neurons exhibited a depolarized ΔΨm. Overexpression of wild-type PINK1 restored hyperpolarized ΔΨm and thread-like mitochondrial morphology and inhibited ROS formation in PINK1-null dopaminergic cells.",
          "judgment": "Yes",
          "reasoning": "The study included both 'Normal/Negative/Wild type' (wild-type PINK1) and 'Abnormal/Positive/Null' (PINK1-/- neurons) controls. Replicates were used, as indicated by statements such as 'n=5 experiments'.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "No known pathogenic or benign variants were used as controls. No variants tested that reach P/LP or B/LB criteria without relying on PS3/BS3 evidence themselves.",
          "judgment": "No",
          "reasoning": "The study did not use any known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Compared to wild-type PINK1, PARK6 mutant (G309D) ... was defective in increasing TMRM fluorescence signal and reversing depolarized ΔΨm of PINK1-deficient SN dopaminergic cells.",
          "judgment": "No",
          "reasoning": "There are no sufficient statistical analyses reported (no OddsPath or similar calculation is presented).",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used wild-type PINK1 as a benign control and PINK1-/- as a pathogenic control. No additional benign or pathogenic variant controls were used.",
          "judgment": "No",
          "reasoning": "Only 2 total control variants were used.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G309D variant is shown to be defective in rescuing the mitochondrial membrane potential defect in PINK1 deficient cells, which supports a pathogenic role for this variant. However, given the lack of robust statistics and limited variant controls, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "E",
          "alt": "G",
          "position": "417"
        },
        "variant_string_id": "PINK1 E417G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PTEN-induced kinase 1 (PINK1) gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to exert neuroprotective effect on SN dopaminergic cells by acting as a mitochondrial Ser/Thr protein kinase.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as loss of neuroprotective effect in SN dopaminergic cells due to mutated PINK1's impaired Ser/Thr kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1 is required for maintaining mitochondrial membrane potential (ΔΨm) and mitochondrial morphology of cultured SN dopaminergic neurons and exerts its neuroprotective effect by inhibiting ROS formation.",
          "judgment": "Yes",
          "reasoning": "The assays used (mitochondrial membrane potential, morphology, and ROS formation) are directly relevant to the defined disease mechanism of mitochondrial dysfunction leading to neurodegeneration.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "PINK1-/- SN dopaminergic neurons exhibited a depolarized ΔΨm. Overexpression of wild-type PINK1 restored hyperpolarized ΔΨm and thread-like mitochondrial morphology and inhibited ROS formation in PINK1-null dopaminergic cells.",
          "judgment": "Yes",
          "reasoning": "The study included both 'Normal/Negative/Wild type' (wild-type PINK1) and 'Abnormal/Positive/Null' (PINK1-/- neurons) controls. Replicates were used, as indicated by statements such as 'n=5 experiments'.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "No known pathogenic or benign variants were used as controls. No variants tested that reach P/LP or B/LB criteria without relying on PS3/BS3 evidence themselves.",
          "judgment": "No",
          "reasoning": "The study did not use any known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Compared to wild-type PINK1, PARK6 mutant (E417G) ... was defective in increasing TMRM fluorescence signal and reversing depolarized ΔΨm of PINK1-deficient SN dopaminergic cells.",
          "judgment": "No",
          "reasoning": "There are no sufficient statistical analyses reported (no OddsPath or similar calculation is presented).",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used wild-type PINK1 as a benign control and PINK1-/- as a pathogenic control. No additional benign or pathogenic variant controls were used.",
          "judgment": "No",
          "reasoning": "Only 2 total control variants were used.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E417G variant is shown to be defective in rescuing the mitochondrial membrane potential defect in PINK1 deficient cells, which supports a pathogenic role for this variant. However, given the lack of robust statistics and limited variant controls, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "*",
          "alt": "*",
          "position": "CA145"
        },
        "variant_string_id": "PINK1 *CA145"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PTEN-induced kinase 1 (PINK1) gene cause recessive familial type 6 of Parkinson's disease (PARK6). PINK1 is believed to exert neuroprotective effect on SN dopaminergic cells by acting as a mitochondrial Ser/Thr protein kinase.",
          "judgment": "Yes",
          "reasoning": "The paper defines the disease mechanism as loss of neuroprotective effect in SN dopaminergic cells due to mutated PINK1's impaired Ser/Thr kinase activity."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1 is required for maintaining mitochondrial membrane potential (ΔΨm) and mitochondrial morphology of cultured SN dopaminergic neurons and exerts its neuroprotective effect by inhibiting ROS formation.",
          "judgment": "Yes",
          "reasoning": "The assays used (mitochondrial membrane potential, morphology, and ROS formation) are directly relevant to the defined disease mechanism of mitochondrial dysfunction leading to neurodegeneration.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "PINK1-/- SN dopaminergic neurons exhibited a depolarized ΔΨm. Overexpression of wild-type PINK1 restored hyperpolarized ΔΨm and thread-like mitochondrial morphology and inhibited ROS formation in PINK1-null dopaminergic cells.",
          "judgment": "Yes",
          "reasoning": "The study included both 'Normal/Negative/Wild type' (wild-type PINK1) and 'Abnormal/Positive/Null' (PINK1-/- neurons) controls. Replicates were used, as indicated by statements such as 'n=5 experiments'.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "No known pathogenic or benign variants were used as controls. No variants tested that reach P/LP or B/LB criteria without relying on PS3/BS3 evidence themselves.",
          "judgment": "No",
          "reasoning": "The study did not use any known pathogenic or benign variants as controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Compared to wild-type PINK1, PARK6 mutant (CA145) ... was defective in increasing TMRM fluorescence signal and reversing depolarized ΔΨm of PINK1-deficient SN dopaminergic cells.",
          "judgment": "No",
          "reasoning": "There are no sufficient statistical analyses reported (no OddsPath or similar calculation is presented).",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study used wild-type PINK1 as a benign control and PINK1-/- as a pathogenic control. No additional benign or pathogenic variant controls were used.",
          "judgment": "No",
          "reasoning": "Only 2 total control variants were used.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The CA145 variant is shown to be defective in rescuing the mitochondrial membrane potential defect in PINK1 deficient cells, which supports a pathogenic role for this variant. However, given the lack of robust statistics and limited variant controls, the strength is PS3_supporting."
    }
  ]
}
```